Inventor
CHRISTIAN ROSE C
US7 patents
Patents
7 patentsUS9434778B2Sep 6, 2016
Modified FGF-21 polypeptides comprising an internal deletion and uses thereof
BRISTOL MYERS SQUIBB CO31 citations97
US10189883B2Jan 29, 2019
Therapeutic uses of modified FGF-21 polypeptides
BRISTOL MYERS SQUIBB CO12 citations92
US9631004B2Apr 25, 2017
Modified FGF-21 polypeptides comprising an internal deletion and uses thereof
BRISTOL MYERS SQUIBB CO12 citations92
US11248031B2Feb 15, 2022
Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptides
BRISTOL MYERS SQUIBB CO4 citations83
US10377806B2Aug 13, 2019
Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptides and uses thereof
BRISTOL MYERS SQUIBB CO6 citations83
US12247058B2Mar 11, 2025
Nucleic acids encoding modified FGF-21 polypeptides, vectors and cells containing, and use thereof
BRISTOL MYERS SQUIBB CO0 citations62
US11642395B2May 9, 2023
Modified fibroblast growth factor 21 (FGF-21) for use in methods for treating nonalcoholic steatohepatitis (NASH)
BRISTOL MYERS SQUIBB CO1 citations56